{"count": 2, "results": [{"_id": "10758046", "pmid": 10758046, "title": "Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan.", "journal": "Circulation", "authors": ["Schiffrin EL", "Park JB", "Intengan HD", "Touyz RM"], "date": "2000-04-11T00:00:00Z", "doi": "10.1161/01.cir.101.14.1653", "meta_date_publication": "2000 Apr 11", "meta_volume": "101", "meta_issue": "14", "meta_pages": "1653-9", "score": 50050.195, "text_hl": "Because angiotensin II may be pivotal in some of these @DISEASE_Vascular_Diseases @DISEASE_MESH:D014652 @@@vascular abnormalities@@@, we tested the hypothesis that the angiotensin type 1 (AT(1)) receptor antagonist @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@losartan@@@, in contrast to the beta-blocker @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@, would correct @<m>DISEASE_Disease_Resistance</m> @DISEASE_MESH:D060467 @@@resistance artery abnormalities@@@ in @SPECIES_9606 @@@patients@@@ with @DISEASE_Essential_Hypertension @DISEASE_MESH:D000075222 @@@essential hypertension@@@. ", "citations": {"NLM": "Schiffrin EL, Park JB, Intengan HD, Touyz RM. Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan. Circulation. 2000 Apr 11;101(14):1653-9. PMID: 10758046", "BibTeX": "@article{10758046, title={Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan.}, author={Schiffrin EL and Park JB and Intengan HD and Touyz RM}, journal={Circulation}, volume={101}, number={14}, pages={1653-9}}"}}, {"_id": "2043298", "pmid": 2043298, "title": "Comparison of the effects of atenolol and nifedipine on glucose, insulin, and lipid metabolism in patients with hypertension.", "journal": "Am J Hypertens", "authors": ["Sheu WH", "Swislocki AL", "Hoffman B", "Chen YD", "Reaven GM"], "date": "1991-03-01T00:00:00Z", "doi": "10.1093/ajh/4.3.199", "meta_date_publication": "1991 Mar", "meta_volume": "4", "meta_issue": "3 Pt 1", "meta_pages": "199-205", "score": 50049.965, "text_hl": "The changes in day-long plasma @CHEMICAL_Glucose @CHEMICAL_MESH:D005947 @@@glucose@@@ and @GENE_INS @GENE_3630 @@@insulin@@@ responses suggested that @<m>DISEASE_Disease_Resistance</m> @DISEASE_MESH:D060467 @@@resistance@@@ to @GENE_INS @GENE_3630 @@@insulin@@@-stimulated @CHEMICAL_Glucose @CHEMICAL_MESH:D005947 @@@glucose@@@ uptake had increased in association with @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ treatment and decreased following @CHEMICAL_Nifedipine @CHEMICAL_MESH:D009543 @@@nifedipine@@@. ", "citations": {"NLM": "Sheu WH, Swislocki AL, Hoffman B, Chen YD, Reaven GM. Comparison of the effects of atenolol and nifedipine on glucose, insulin, and lipid metabolism in patients with hypertension. Am J Hypertens. 1991 Mar;4(3 Pt 1):199-205. PMID: 2043298", "BibTeX": "@article{2043298, title={Comparison of the effects of atenolol and nifedipine on glucose, insulin, and lipid metabolism in patients with hypertension.}, author={Sheu WH and Swislocki AL and Hoffman B and Chen YD and Reaven GM}, journal={Am J Hypertens}, volume={4}, number={3 Pt 1}, pages={199-205}}"}}]}